Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IoM chaparral monograph

This article was originally published in The Tan Sheet

Executive Summary

Institute of Medicine will meet Aug. 30-31 to discuss its chaparral draft monograph, the first prototype monograph developed as part of institute's Proposed Framework for Evaluating the Safety of Dietary Supplements. Under the framework, monographs will be prepared on supplements selected for safety review to help guide further FDA action ("1The Tan Sheet" July 29, 2002, p. 4). The 2chaparral monograph, which does not reach safety conclusions, will be discussed in public session the afternoon of Aug. 30. Written comments will be accepted...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094448

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel